Water Island Capital’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
Other funds holding DAWN
Water Island Capital's DAWN Position: Q2 2026 in Review
Water Island Capital sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 944,247 shares — an estimated $20.2M sold.
Water Island Capital first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $20.2M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.
- Water Island Capital reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Water Island Capital sold 944,247 Day One Biopharmaceuticals shares in Q2 2026, an estimated $20.2M.
- Water Island Capital first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
- Water Island Capital's Day One Biopharmaceuticals position peaked at $20.2M in Q1 2026.
- 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.
Based on Water Island Capital's 13F filing for Q2 2026, filed 14 Aug 2026.